Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Japanese (NIKKEI) Biotech Industry Analysis

UpdatedMay 13, 2026
DataAggregated Company Financials
Companies34
  • 7D0.8%
  • 3M0.07%
  • 1Y-0.6%
  • YTDn/a

Over the last 7 days, the Biotech industry has remained flat, although notably GNI Group gained 6.8%. In line with that, the industry has also been flat over the past 12 months. As for the next few years, earnings are expected to grow by 42% per annum.

Industry Valuation and Performance

Has the Japanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 14 May 2026JP¥1.1tJP¥202.7b-JP¥49,407,646,682.0060x-23.1x5.6x
Sat, 11 Apr 2026JP¥1.2tJP¥202.7b-JP¥49,292,644,682.0061.5x-23.4x5.7x
Mon, 09 Mar 2026JP¥1.3tJP¥200.5b-JP¥50,373,794,682.00321.2x-25.7x6.5x
Wed, 04 Feb 2026JP¥1.1tJP¥198.6b-JP¥70,466,747,000.0058.6x-15.3x5.4x
Fri, 02 Jan 2026JP¥992.9bJP¥198.7b-JP¥70,727,387,000.0052.7x-14x5x
Sun, 30 Nov 2025JP¥1.1tJP¥196.3b-JP¥69,178,659,000.0052.8x-15.9x5.6x
Tue, 28 Oct 2025JP¥1.1tJP¥197.7b-JP¥65,502,224,000.0065.4x-17.2x5.7x
Thu, 25 Sep 2025JP¥1.2tJP¥197.7b-JP¥65,794,561,000.0064.9x-18.2x6x
Sat, 23 Aug 2025JP¥1.2tJP¥193.5b-JP¥68,135,862,000.00131.9x-17.2x6.1x
Mon, 21 Jul 2025JP¥1.1tJP¥218.2b-JP¥43,758,363,000.00100.8x-25.4x5.1x
Wed, 18 Jun 2025JP¥1.2tJP¥218.3b-JP¥41,682,114,000.00101.2x-29.2x5.6x
Fri, 16 May 2025JP¥1.1tJP¥209.9b-JP¥37,783,201,000.0015.5x-28.1x5.1x
Sun, 13 Apr 2025JP¥971.3bJP¥207.7b-JP¥38,746,927,000.0013.9x-25.1x4.7x
Tue, 11 Mar 2025JP¥980.4bJP¥207.4b-JP¥38,725,942,000.0015.7x-25.3x4.7x
Thu, 06 Feb 2025JP¥976.0bJP¥207.3b-JP¥13,596,922,000.0020.1x-71.8x4.7x
Sat, 04 Jan 2025JP¥1.1tJP¥206.4b-JP¥12,718,356,000.0022.3x-85.2x5.2x
Mon, 02 Dec 2024JP¥1.1tJP¥207.2b-JP¥12,080,899,000.0022.8x-92.5x5.4x
Wed, 30 Oct 2024JP¥1.1tJP¥214.3b-JP¥3,941,502,000.0022.3x-278.1x5.1x
Fri, 27 Sep 2024JP¥1.1tJP¥214.3b-JP¥2,078,229,000.0021.2x-544.8x5.3x
Sun, 25 Aug 2024JP¥1.0tJP¥210.1b-JP¥580,439,000.0014.2x-1768.1x4.9x
Tue, 23 Jul 2024JP¥1.0tJP¥187.7b-JP¥15,871,901,000.0092.5x-66x5.6x
Thu, 20 Jun 2024JP¥892.7bJP¥187.7b-JP¥15,773,284,000.0081.8x-56.6x4.8x
Sat, 18 May 2024JP¥769.6bJP¥195.0b-JP¥14,649,545,000.0083.5x-52.5x3.9x
Mon, 15 Apr 2024JP¥752.6bJP¥194.2b-JP¥15,746,837,000.0066.1x-47.8x3.9x
Wed, 13 Mar 2024JP¥787.9bJP¥193.6b-JP¥19,603,997,000.0060.6x-40.2x4.1x
Fri, 09 Feb 2024JP¥745.0bJP¥222.4b-JP¥12,442,827,000.0016.9x-59.9x3.3x
Sun, 07 Jan 2024JP¥802.9bJP¥222.3b-JP¥12,668,455,000.0017.4x-63.4x3.6x
Tue, 05 Dec 2023JP¥800.2bJP¥221.9b-JP¥12,426,487,000.0016.9x-64.4x3.6x
Thu, 02 Nov 2023JP¥724.0bJP¥223.0b-JP¥14,478,735,000.0018.3x-50x3.2x
Sat, 30 Sep 2023JP¥847.8bJP¥223.0b-JP¥14,518,735,000.0026.2x-58.4x3.8x
Mon, 28 Aug 2023JP¥896.5bJP¥225.1b-JP¥19,814,131,000.0047.6x-45.2x4x
Wed, 26 Jul 2023JP¥914.5bJP¥223.7b-JP¥20,836,669,000.0047.8x-43.9x4.1x
Fri, 23 Jun 2023JP¥997.1bJP¥223.2b-JP¥20,139,670,000.0062.1x-49.5x4.5x
Sun, 21 May 2023JP¥915.5bJP¥218.6b-JP¥25,244,669,000.0032.1x-36.3x4.2x
Price to Earnings Ratio

-36.3x


Total Market Cap: JP¥915.5bTotal Earnings: -JP¥25,244,669,000.00Total Revenue: JP¥218.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Biotech Industry Price to Earnings3Y Average -115.2x202420252026
Current Industry PE
  • Investors are optimistic on the Japanese Biotechnology industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 4.8x is lower than the industry's current PS ratio of 5.6x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Revenues have also declined 2.5% per year.
  • This means overall sales from these companies are declining and losses are subsequently expanding as well.

Industry Comparison

How does Japanese Biotech compare with similar industries?

JP Market3.78%
Healthcare-1.70%
Biotech0.83%
Biotech0.83%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
2160 GNI GroupJP¥3.24k7.3%
+JP¥12.3b		30.9%PS6.7x
4592 SanBioJP¥2.03k2.8%
+JP¥4.4b		-24.1%PB11.6x
7774 Japan Tissue EngineeringJP¥634.0014.6%
+JP¥3.3b		7.3%PS11.8x
4593 Healios K.KJP¥344.003.3%
+JP¥1.5b		7.5%PS446.5x
219A HeartseedJP¥1.87k3.4%
+JP¥1.4b		-20.0%PE72x

Latest News

7777
JP¥493.00
3-D Matrix
7D
-2.0%
1Y
270.7%
4564
JP¥21.00
OncoTherapy Science
7D
-8.7%
1Y
-8.7%
219A
JP¥1,865.00
Heartseed
7D
3.4%
1Y
-20.0%
4563
JP¥52.00
AnGes
7D
-3.7%
1Y
-16.1%
2160
JP¥3,240.00
GNI Group
7D
7.3%
1Y
30.9%
4587
JP¥1,118.50
PeptiDream
7D
-4.2%
1Y
-34.7%
Narrative Update • May 08

4587: Out Licensing Progress And Autoimmune Pipeline Will Support Future Upside

Analysts have trimmed their price target on PeptiDream to ¥1,600 from ¥2,600, citing slower than expected progress in product out licensing and adjustments to fair value, discount rate, revenue growth, profit margin and future P/E assumptions. Analyst Commentary Bearish analysts are flagging that the lower ¥1,600 price target reflects reduced confidence in how quickly PeptiDream can execute on its product out licensing plans and convert its pipeline into revenue.
4588
JP¥2,746.00
Oncolys BioPharma
7D
1.1%
1Y
413.3%
7774
JP¥634.00
Japan Tissue Engineering
7D
14.6%
1Y
7.3%
4597
JP¥29.00
Solasia Pharma K.K
7D
-9.4%
1Y
-9.4%
Analysis Article • Apr 17

We're Hopeful That Solasia Pharma K.K (TSE:4597) Will Use Its Cash Wisely

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
4592
JP¥2,026.00
SanBio
7D
2.8%
1Y
-24.1%
4593
JP¥344.00
Healios K.K
7D
3.3%
1Y
7.5%
190A
JP¥137.00
Chordia Therapeutics
7D
-11.0%
1Y
-38.3%
177A
JP¥1,600.00
Kohjin Bio
7D
8.7%
1Y
-13.3%
4599
JP¥307.00
StemRIM
7D
2.7%
1Y
4.1%
4594
JP¥55.00
BrightPath Biotherapeutics
7D
-6.8%
1Y
31.0%
4978
JP¥169.00
ReproCELL
7D
-2.3%
1Y
5.0%